Advertisement

Once the top-selling diabetes pill in the world, Avandia was severely restricted by the Food and Drug Administration after reports that taking the drug could raise the risk of heart attack. But now, the agency may be on the verge of reversing those restrictions.

Advertisement
Advertisement